Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Cefazolin Prophylaxis and CSF Levels in Ventricular Shunt Surgery

Official title: Cefazolin Antibiotic Prophylaxis in Ventricular Shunt Surgery: Determination of Cerebrospinal Fluid(CSF) Concentration During Valve Implantation

Run by University Hospital, Strasbourg, France · NCT07067736 · Data updated 2026-11-12

This study tests whether a standard 2 g dose of cefazolin given before ventricular shunt surgery yields enough drug in the brain’s fluid to help prevent valve infections.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment15 (estimated)
SponsorUniversity Hospital, Strasbourg, France
Academic / other
Locations1 site (Strasbourg)
StatusRecruiting
StartedFebruary 1, 2026
Main results expectedAugust 30, 2026
Study endsAugust 30, 2026
Registry record updatedAugust 20, 2026
Trial IDNCT07067736 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) undergoing planned ventricular shunt surgery at Hautepierre University Hospital, Strasbourg.

Probably not a fit

Patients with cefazolin allergy or other antibiotic prophylaxis used, or those not undergoing valve implantation, may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will measure cefazolin concentration in cerebrospinal fluid after a standard 2 g prophylactic dose given to adults undergoing ventricular shunt placement. The goal is to see if CSF levels are adequate to prevent infection of the valve. They will compare observed concentrations with existing pharmacokinetic models and explore factors that might explain any differences. The study is conducted at Hôpitaux Universitaires de Strasbourg and involves only patients planned for shunt surgery without active infection or allergy to cefazolin.

Why it matters

Potential benefit: If cefazolin levels are sufficient, this could support effective infection prevention for shunt valves.

How similar studies have gone: Previous pharmacokinetic analyses have explored cefazolin diffusion in CSF, but this study focuses on direct CSF concentration during shunt surgery for decision impact.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Age \>18 years and programmed for a ventricular shunt surgery at the Hautepierre university hospital in Strasbourg.

Exclusion Criteria:

* Age \<18 years old
* Pregnant women
* Infected patients
* Known cefazolin allergy
* Other molecule used for the antibiotic prophylaxis
* Guardianship or conservatorship
* Patients under curative antibiotherapy
* Non sterile pre operative CSF
* Refusal to participate

Where it's running

  • Hôpitaux Universitaires de Strasbourg
    Strasbourg, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.